Search clinical trials for: EG-301

Total 4027 results

Evergreen Therapeutics, Inc.

Not yet recruiting

Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to dAMD

Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
EyeGene Inc.
Novotech (Australia) Pty Limited

Active, not recruiting

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-COVID and EG-COVARo in Healthy Adult Volunteers

COVID-19 Vaccine

Australia
EyeGene Inc.
Novotech (Australia) Pty Limited

Completed

Study to Assess the Safety, Tolerability and Explore the Immunogenicity of EG-HZ in Healthy Adult Volunteers

Prevention of Herpes Zoster (HZ)

Australia
Assistance Publique - Hôpitaux de Paris
University of Paris 5 - Rene Descartes

Completed

Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women (CBP-HOPE)

Liver Cirrhosis, Biliary

France
Universidad Nacional de Educación a Distancia
Ministerio de Economía y Competitividad, Spain; Spanish Ministry of Education...

Completed

Applying the Spanish Version of the UP-A as a Universal School-based Anxiety and Depression Prevention Program

Depression | Anxiety
Sun Yat-sen University

Unknown

ESI With EUS to Differentiate T3 and T4 ESCC (ESI)

Esophageal Cancer

China
enGene, Inc.

Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Superficial Bladder Cancer | Non-muscle Invasive Bladder Cancer With Carcinoma in Situ

United States
Dong-A University

Unknown

Multidetector Coronary CT In Vasospastic Angina

Vasospastic Angina

Korea, Republic of
Société des Produits Nestlé (SPN)

Not yet recruiting

Efficacy of Two HMOs in Chinese Infants

Healthy Infants
Istanbul Arel University

Completed

Effect of Extracorporeal Shock Wave Therapy in Impingement Syndrome (ESWT)

Shoulder Impingement Syndrome | Trigger Point Pain

Turkey
EGEN, Inc.

Terminated

A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients

Colorectal Cancer

United States
EyeGene Inc.

Recruiting

Study to Safety, Tolerability and Immunogenicity of EG-COVII in Healthy Adult

COVID-19

Australia
Hacettepe University

Completed

Relaxation Training by Tele-Rehabilitation in Patients With Breast Cancer

Breast Cancer

Turkey
Martin-Luther-Universität Halle-Wittenberg

Completed

Home-based Balance Training Using Wii Fit After Stroke: A Feasibility Study (WiiMobil)

Stroke

Germany
Mayo Clinic
IntroMedic Co., Ltd.

Completed

Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy

Barrett's Esophagus

United States
Case Comprehensive Cancer Center

Recruiting

Detection of Barrett s Esophagus in Patients Without GERD Symptoms

Barrett's Esophagus

United States
University of Sao Paulo

Completed

Practice Structure on Motor Learning in Post-Stroke Patients

Stroke

Brazil
Hookipa Biotech GmbH

Recruiting

HB-302/HB-301 Therapy in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Metastatic

United States
University of Seville

Recruiting

Effects of Osteopathic Manual Therapy on Infant Colic

Colic, Infantile

Spain
Konkuk University Hospital

Completed

The Efficacy of i-Scan for Detecting Reflux Esophagitis

Gastroesophageal Reflux Disease | Reflux Esophagitis

Korea, Republic of
NewG Lab Pharma

Active, not recruiting

KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma | Fibrolamellar Carcinoma

Korea, Republic of
University of Sao Paulo General Hospital
Instituto do Cancer do Estado de São Paulo; Instituto Nacional de Cancer, Brazil and other collaborators

Unknown

Study of TENS in Reducing Symptoms of Peripheral Neuropathy Induced by Chemotherapy (CIPN)

Pain | Neuritis | Peripheral Neuropathy | Paresthesia

Brazil
Swiss Tropical & Public Health Institute
Pevion Biotech Ltd; Mymetics Corporation

Completed

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania (PMAL03)

Falciparum Malaria

Tanzania
Ospedale San Raffaele

Unknown

Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19) (COMBAT-19)

Covid-19 | Acute Respiratory Failure | ARDS, Human | Sars-CoV2 | Viral Pneumonia

Italy
Orion Corporation, Orion Pharma
Bayer

Completed

Mass Balance, Pharmacokinetics, Biotransformation and Bioavailability Study of ODM-201 in Healthy Male Subjects (ARIADME)

Healthy

United Kingdom
University of Extremadura

Completed

The Influence of the Manipulation of the Sacroiliac Joint on Low Back Pain

Low Back Pain | Sacroiliac Disorder

Spain
Chong Kun Dang Pharmaceutical

Completed

A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)

Dyslipidemias

Korea, Republic of
Fundación Hospital de Madrid

Completed

Utility of ICD Electrograms During Ventricular Tachycardia Ablation

Sustained Monomorphic Ventricular Tachycardia

Spain
Instituto Ecuatoriano de Enfermedades Digestivas

Completed

New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy

Gastritis | Atrophic Gastritis | Helicobacter Pylori Associated Gastritis

Ecuador
University of Zurich

Not yet recruiting

Endoscopic Characterisation of Inflammation in EoE (ECI-EoE)

Eosinophilic Esophagitis
Sorrento Therapeutics, Inc.

Withdrawn

A Study of STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Diffuse Large B Cell Lymphoma | Biliary Tract Cancer | Peripheral T Cell Lymphoma | Extranodal NK T Cell Lymphoma, Nasal
The Catholic University of Korea

Unknown

Efficacy of 311-nm Ti:Sapphire Laser Versus 308-nm Excimer Laser Treatment in Vitiligo

Vitiligo

Korea, Republic of
Flame Biosciences

Withdrawn

Phase 1/2a Study to Evaluate FL-301 in Patients With Advanced Solid Tumors

Gastric Cancer | Solid Tumor | Pancreas Cancer
Woolcock Institute of Medical Research
University of Sydney

Completed

Cannabinol Use in Patients With Insomnia Disorder (CUPID)

Insomnia Disorder

Australia
Universidade Federal do Para

Completed

The Effect of an Experimental Gel Based on Acmella Oleracea Extract in Reducing Post-bleaching Tooth Sensitivity

Pain | Tooth Bleaching | Dentin Desensitizing Agents

Brazil
Sensei Biotherapeutics, Inc.
Accelovance

Completed

Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients

Prostate Cancer

United States
Medtronic Cardiovascular

Completed

Medtronic HAMMOCK Post Approval Study

Heart Valve Diseases

United States, Germany, Poland
Shandong University

Completed

Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy (CLE)

Stomach Neoplasms | Precancerous Conditions

China
Evergreen Therapeutics, Inc.

Withdrawn

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

COVID-19 Pneumonia
Acibadem University

Recruiting

Comparing Machine Guided VR Based Training With Educator Guided Training in Metaverse

Virtual Reality | Serious Game | Advanced Cardiac Life Support

Turkey
Kiora Pharmaceuticals, Inc.

Recruiting

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS) (ABACUS)

Retinitis Pigmentosa | Choroideremia

Australia
LYSOGENE

Completed

Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy

Mucopolysaccharidosis Type III A | Sanfilippo Disease Type A

France
LYSOGENE

Completed

Intracerebral Gene Therapy for Sanfilippo Type A Syndrome

Mucopolysaccharidosis Type III A | Sanfilippo Disease Type A

France
University of Alabama at Birmingham

Recruiting

NTX-301 in MDS/AML

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia

United States
Lumen Bioscience, Inc.

Completed

A Study to Determine the Tolerability of Intranasal LMN-301

COVID-19

Australia
Kodiak Sciences Inc

Terminated

Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO

Diabetic Macular Edema | Retinal Vein Occlusion | Wet Age-related Macular Degeneration

United States
Oncolys BioPharma Inc
Medigen Biotechnology Corporation

Unknown

Phase I Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Taiwan, Korea, Republic of
Sensei Biotherapeutics, Inc.

Withdrawn

SNS-301 Monotherapy in High Risk MDS and CMML

Myelodysplastic Syndromes | Chronic Myelomonocytic Leukemia (CMML)
Celldex Therapeutics

Completed

A Study to Evaluate CDX-301 (rhuFlt3L) in Healthy Volunteers

Healthy

United States
Benitec Biopharma, Inc.

Recruiting

A Study to Evaluate the Safety and Clinical Activity of Intramuscular Doses of BB-301 Administered to Subjects With Oculopharyngeal Muscular Dystrophy With Dysphagia

Oculopharyngeal Muscular Dystrophy

United States

Search clinical trials for: EG-301

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations